Stephen Boyd Wiles 13D and 13G filings for Clearside Biomedical, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-01 06:09 am Purchase |
2025-03-31 | 13G | Clearside Biomedical, Inc. CLSD |
Stephen Boyd Wiles | 4,003,553 5.200% |
4,003,553 (New Position) |
Filing |